Carbonic Anhydrase Inhibitors in the Treatment of Glaucoma. Review. Part II
Topical and systemic carbonic anhydrase inhibitors (CAIs) are widely used in the treatment of glaucoma for reducing intraocular pressure. This part of the review describes the characteristics of systemic CAIs, their side effects and the ways to overcome them, as well as contraindications. The use of...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Ophthalmology Publishing Group
2020-12-01
|
| Series: | Oftalʹmologiâ |
| Subjects: | |
| Online Access: | https://www.ophthalmojournal.com/opht/article/view/1357 |
| _version_ | 1797875395737944064 |
|---|---|
| author | N. I. Kurysheva |
| author_facet | N. I. Kurysheva |
| author_sort | N. I. Kurysheva |
| collection | DOAJ |
| description | Topical and systemic carbonic anhydrase inhibitors (CAIs) are widely used in the treatment of glaucoma for reducing intraocular pressure. This part of the review describes the characteristics of systemic CAIs, their side effects and the ways to overcome them, as well as contraindications. The use of CAIs during pregnancy is considered. Particular attention is paid to the antioxidant activity of CAIs and the promising development of hybrid forms based on the existing CAIs as a part of a multipurpose glaucoma treatment strategy. |
| first_indexed | 2024-04-10T01:47:00Z |
| format | Article |
| id | doaj.art-b04ad477dc0945abb10301b6c4dcbd4f |
| institution | Directory Open Access Journal |
| issn | 1816-5095 2500-0845 |
| language | Russian |
| last_indexed | 2024-04-10T01:47:00Z |
| publishDate | 2020-12-01 |
| publisher | Ophthalmology Publishing Group |
| record_format | Article |
| series | Oftalʹmologiâ |
| spelling | doaj.art-b04ad477dc0945abb10301b6c4dcbd4f2023-03-13T09:08:41ZrusOphthalmology Publishing GroupOftalʹmologiâ1816-50952500-08452020-12-0117467668210.18008/1816-5095-2020-4-676-682690Carbonic Anhydrase Inhibitors in the Treatment of Glaucoma. Review. Part IIN. I. Kurysheva0Медико-биологический университет инноваций и непрерывного образования ФГБУ ГНЦ РФ «Федеральный биофизический центр им. А.И. Бурназяна» Федерального медико-биологического агентства России; Консультативно-диагностический отдел Центра офтальмологии Федерального медико-биологического агентства РоссииTopical and systemic carbonic anhydrase inhibitors (CAIs) are widely used in the treatment of glaucoma for reducing intraocular pressure. This part of the review describes the characteristics of systemic CAIs, their side effects and the ways to overcome them, as well as contraindications. The use of CAIs during pregnancy is considered. Particular attention is paid to the antioxidant activity of CAIs and the promising development of hybrid forms based on the existing CAIs as a part of a multipurpose glaucoma treatment strategy.https://www.ophthalmojournal.com/opht/article/view/1357ингибиторы карбоангидразыглаукомапобочные действиябеременностьантиоксидантная активностьводянистая влагамногоцелевая стратегия в лечении глаукомы |
| spellingShingle | N. I. Kurysheva Carbonic Anhydrase Inhibitors in the Treatment of Glaucoma. Review. Part II Oftalʹmologiâ ингибиторы карбоангидразы глаукома побочные действия беременность антиоксидантная активность водянистая влага многоцелевая стратегия в лечении глаукомы |
| title | Carbonic Anhydrase Inhibitors in the Treatment of Glaucoma. Review. Part II |
| title_full | Carbonic Anhydrase Inhibitors in the Treatment of Glaucoma. Review. Part II |
| title_fullStr | Carbonic Anhydrase Inhibitors in the Treatment of Glaucoma. Review. Part II |
| title_full_unstemmed | Carbonic Anhydrase Inhibitors in the Treatment of Glaucoma. Review. Part II |
| title_short | Carbonic Anhydrase Inhibitors in the Treatment of Glaucoma. Review. Part II |
| title_sort | carbonic anhydrase inhibitors in the treatment of glaucoma review part ii |
| topic | ингибиторы карбоангидразы глаукома побочные действия беременность антиоксидантная активность водянистая влага многоцелевая стратегия в лечении глаукомы |
| url | https://www.ophthalmojournal.com/opht/article/view/1357 |
| work_keys_str_mv | AT nikurysheva carbonicanhydraseinhibitorsinthetreatmentofglaucomareviewpartii |